Klothos Neurosciences Inc. (KLTO)
Delisted
16 Mar 2026
NASDAQ (CM) NASDAQ (CM) Primary $
0. 38
-0.03
-7.0958%
$
20.08M Market Cap
- P/E Ratio
- Div Yield
95,000 Volume
- Eps
$ 0.41
Previous Close Investors:
Day Range
0.37 0.41
Year Range
0.11 3.91
Want to track KLTO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr.
Prismmediawire | 1 year ago
